Skip to content

Enhanced Recovery After Surgery in Major Intrabdominal Procedures.

Enhanced Recovery After Surgery (ERAS) Versus Conventional Postoperative Care in Patients Undergoing Major Intra-abdominal Surgery.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01400711
Enrollment
54
Registered
2011-07-22
Start date
2010-10-31
Completion date
2011-04-30
Last updated
2011-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication of Surgical and Medical Care.

Keywords

Fast-tract surgery, Enhanced recovery after surgery, multimodal surgery.

Brief summary

Enhanced Recovery After Surgery (ERAS) programs have been introduced with aims of attenuating the stress response to surgery and enabling rapid recovery. There is strong evidence of the usefulness of the ERAS programs in patients undergoing colorectal surgery in terms of significantly reduced postoperative complications and shorter length of hospital stay, compared to the patients of traditional treatment. However, few studies exist about the implication of ERAS programs in major upper abdominal surgery patients. The aim of this study was to compare morbidity, mortality and length of stay in patients undergoing major intrabdominal surgery, including upper and lower gastrointestinal, receiving either conventional postoperative care or an ERAS program.

Interventions

Patient's education before surgery, early mobilization and oral feeding after surgery, no opioids analgesics.

Nasogastric tube until bowel function, late oral eating, opioid analgesics.

Sponsors

St. Andrew's General Hospital, Patras, Greece
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Elective surgery * ASA grade \< 4

Exclusion criteria

* Emergency surgery * ASA grade \> 3

Design outcomes

Primary

MeasureTime frame
Morbidity.30 days after surgery

Secondary

MeasureTime frame
Mortality.30 days after surgery

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026